PhageTech, Inc.

PhageTech, Inc is a California-based, developmental stage company applying an innovative approach for detecting disease markers in body fluids including urine and blood. Compared to current antibody-based assays, PhageTech’s approach could offer improved sensitivity and performance. Furthermore, our technology has the potential to be more stable and less expensive than current testing methods.

PhageTech’s core technology, developed by two research groups at the University of California, Irvine, utilizes **Phage Display** to create highly specific biosensors. We are focused on developing rapid and accurate diagnostic screening for diseases like prostate cancer and kidney disease, impacting the administration of health care around the world.

Our technology platform promises to deliver results at a fraction of current costs, offering a significant advancement in **In Vitro Diagnostics** and **Medical Sensors**. We are dedicated to revolutionizing disease detection through accessible and affordable testing.